 - Any systemic biologic therapy e.g. interferon, infliximab, daclizumab, etanercept, or adalimumab given intravenously or subcutaneously within 3 months prior to screening. No biologic therapy other than the investigational study treatment will be allowed during the course of the clinical trial. 